tiprankstipranks
Trending News
More News >
Immuno-Biological Laboratories Co., Ltd. (JP:4570)
:4570
Japanese Market

Immuno-Biological Laboratories Co., Ltd. (4570) Ratios

Compare
0 Followers

Immuno-Biological Laboratories Co., Ltd. Ratios

JP:4570's free cash flow for Q1 2025 was ¥0.72. For the 2025 fiscal year, JP:4570's free cash flow was decreased by ¥ and operating cash flow was ¥0.27. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.55 4.94 4.90 4.62 4.95
Quick Ratio
4.26 3.81 3.65 3.36 3.52
Cash Ratio
3.30 2.94 2.85 2.44 2.23
Solvency Ratio
1.08 0.80 0.54 -1.39 -1.19
Operating Cash Flow Ratio
0.00 0.65 0.52 0.10 -0.41
Short-Term Operating Cash Flow Coverage
0.00 1.08 0.88 0.19 -0.72
Net Current Asset Value
¥ 1.19B¥ 1.06B¥ 908.85M¥ 809.57M¥ 792.80M
Leverage Ratios
Debt-to-Assets Ratio
0.10 0.11 0.15 0.16 0.14
Debt-to-Equity Ratio
0.11 0.13 0.19 0.22 0.17
Debt-to-Capital Ratio
0.10 0.12 0.16 0.18 0.15
Long-Term Debt-to-Capital Ratio
0.01 0.02 0.06 0.08 0.07
Financial Leverage Ratio
1.19 1.22 1.28 1.33 1.25
Debt Service Coverage Ratio
1.94 1.56 1.25 -2.49 -1.99
Interest Coverage Ratio
212.14 166.15 92.30 54.40 -190.67
Debt to Market Cap
0.01 0.05 0.05 0.06 0.08
Interest Debt Per Share
20.51 22.06 25.46 25.35 25.19
Net Debt to EBITDA
-2.31 -2.74 -3.89 1.14 1.10
Profitability Margins
Gross Profit Margin
68.81%64.81%63.34%66.28%58.17%
EBIT Margin
28.61%21.78%15.40%-35.18%-38.53%
EBITDA Margin
30.02%23.37%15.69%-41.78%-38.53%
Operating Profit Margin
27.97%21.59%12.77%7.35%-18.87%
Pretax Profit Margin
29.23%21.65%15.26%-35.31%-38.63%
Net Profit Margin
31.59%25.69%22.86%-36.46%-39.96%
Continuous Operations Profit Margin
31.59%25.69%22.86%-36.46%-39.96%
Net Income Per EBT
108.06%118.67%149.78%103.25%103.45%
EBT Per EBIT
104.50%100.25%119.51%-480.72%204.67%
Return on Assets (ROA)
16.24%13.50%11.53%-20.20%-15.17%
Return on Equity (ROE)
20.79%16.45%14.75%-26.86%-18.91%
Return on Capital Employed (ROCE)
16.67%13.38%7.66%4.94%-8.27%
Return on Invested Capital (ROIC)
15.18%12.08%10.33%4.57%-7.87%
Return on Tangible Assets
16.26%13.51%11.55%-20.20%-15.17%
Earnings Yield
2.23%5.57%3.89%-7.64%-8.50%
Efficiency Ratios
Receivables Turnover
5.68 4.19 4.29 3.67 3.72
Payables Turnover
41.99 91.72 68.91 47.03 68.93
Inventory Turnover
0.91 1.07 0.93 0.84 0.83
Fixed Asset Turnover
4.75 5.07 6.01 6.66 5.39
Asset Turnover
0.51 0.53 0.50 0.55 0.38
Working Capital Turnover Ratio
0.85 0.92 0.85 0.88 0.69
Cash Conversion Cycle
458.48 423.11 472.19 524.86 532.77
Days of Sales Outstanding
64.30 87.17 85.05 99.36 98.00
Days of Inventory Outstanding
402.87 339.93 392.44 433.26 440.06
Days of Payables Outstanding
8.69 3.98 5.30 7.76 5.30
Operating Cycle
467.17 427.09 477.49 532.63 538.06
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 19.70 14.36 2.84 -10.01
Free Cash Flow Per Share
0.00 13.30 12.36 2.84 -10.01
CapEx Per Share
0.00 6.41 2.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
0.00 0.67 0.86 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 3.08 7.17 0.00 0.00
Capital Expenditure Coverage Ratio
0.00 3.08 7.17 0.00 0.00
Operating Cash Flow Coverage Ratio
0.00 0.90 0.57 0.11 -0.40
Operating Cash Flow to Sales Ratio
0.00 0.19 0.16 0.03 -0.14
Free Cash Flow Yield
0.00%2.77%2.40%0.70%-3.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
44.80 17.95 25.69 -13.08 -11.77
Price-to-Sales (P/S) Ratio
14.15 4.61 5.87 4.77 4.70
Price-to-Book (P/B) Ratio
8.64 2.95 3.79 3.51 2.23
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 36.10 41.67 143.27 -32.68
Price-to-Operating Cash Flow Ratio
0.00 24.36 35.85 143.27 -32.68
Price-to-Earnings Growth (PEG) Ratio
1.91 0.54 -0.16 -1.09 0.62
Price-to-Fair Value
8.64 2.95 3.79 3.51 2.23
Enterprise Value Multiple
44.83 16.99 33.55 -10.28 -11.11
Enterprise Value
13.60B 3.85B 4.30B 3.41B 2.77B
EV to EBITDA
44.83 16.99 33.55 -10.28 -11.11
EV to Sales
13.46 3.97 5.26 4.29 4.28
EV to Free Cash Flow
0.00 31.08 37.34 128.94 -29.73
EV to Operating Cash Flow
0.00 20.98 32.13 128.94 -29.73
Tangible Book Value Per Share
177.64 162.41 135.61 115.81 146.92
Shareholders’ Equity Per Share
177.81 162.60 135.86 115.81 146.92
Tax and Other Ratios
Effective Tax Rate
-0.08 -0.19 -0.50 -0.03 -0.03
Revenue Per Share
108.54 104.10 87.69 85.32 69.53
Net Income Per Share
34.28 26.74 20.05 -31.11 -27.78
Tax Burden
1.08 1.19 1.50 1.03 1.03
Interest Burden
1.02 0.99 0.99 1.00 1.00
Research & Development to Revenue
0.12 0.12 0.16 0.23 0.29
SG&A to Revenue
0.05 0.05 <0.01 0.01 <0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 0.74 0.72 -0.09 0.37
Currency in JPY